South Korea Clinical Nutrition Market Size, Share, Trends and Forecast by Product, Route of Administration, Application, End User, and Region, 2026-2034

July 2026 | 122 pages | ID: SDC125DCFAA4EN
IMARC Group

Abstracts

The South Korea clinical nutrition market size reached USD 1,139.5 Million in 2025 . Looking forward, the market is expected to reach USD 2,160.0 Million by 2034 , exhibiting a growth rate (CAGR) of 7.00% during 2026-2034 . The market is expanding rapidly, driven by heightened awareness about nutrition's role in managing lifestyle and chronic diseases, and aging demographics boosting demand for tailored enteral and parenteral therapies. Innovations in personalized formulations and stronger hospital-level adoption further enhance access to clinical nutritional support. These trends collectively strengthen the South Korea clinical nutrition market share.

SOUTH KOREA CLINICAL NUTRITION MARKET TRENDS:

Aging Population & Rising Chronic Disease Prevalence

South Korea’s rapidly aging demographic, combined with the increasing incidence of chronic conditions such as obesity, diabetes, cardiovascular disorders, hypertension, and osteoporosis, is a key market driver. As more seniors and urban adults require nutrition therapy alongside clinical interventions, demand grows for enteral and parenteral formulas supporting long-term disease management, recovery protocols, and healthy aging. Preventive and therapeutic nutritional solutions are increasingly adopted within hospitals and care facilities to mitigate comorbidity risk and enhance patient outcomes. Government health campaigns and institutional nutrition strategies further reinforce recognition of clinical nutrition’s role in curbing escalating lifestyle-related disease burden, elevating its relevance in South Korea’s evolving healthcare ecosystem.

Awareness of Nutrition’s Role in Preventive Care & Functional Foods Adoption

The growing consumer consciousness around the health benefits of targeted nutrition, particularly in managing or preventing chronic conditions, has fueled the adoption of medical nutrition products, which is boosting the South Korea clinical nutrition market growth. Alongside this, South Korea’s functional food and health supplement culture aligns closely with preventive wellness goals. Clinical nutrition products that combine therapeutic benefits with palatability and convenience are increasingly accepted in hospital settings and outpatient care. Policies and public health initiatives that promote balanced diets and nutritional education also contribute to greater acceptance of clinical nutrition solutions. This trend enhances trust in enteral and parenteral formulations as viable adjuncts to medication, supporting their integration into both inpatient and domiciliary care settings.

Technological & Healthcare Infrastructure Advancements

South Korea's highly advanced healthcare system and robust infrastructure provide strong support for clinical nutrition adoption. Modern hospitals, widespread clinical nutrition protocols, and government-backed nutritional programs facilitate widespread implementation of enteral and parenteral therapies. Additionally, innovations in personalized nutrition—powered by technologies like AI, big data analytics, and genetic assessment—enable customized nutrition solutions tailored to specific patient conditions. These technological capabilities boost prescription precision and clinical acceptance. Within this regulated, technologically sophisticated environment, both domestic and global firms are increasingly launching clinical nutrition products and therapies, supported by streamlined approvals and collaborative research across academic–medical industry partnerships. This robust ecosystem reinforces market growth and product penetration.

SOUTH KOREA CLINICAL NUTRITION MARKET SEGMENTATION:

IMARC Group provides an analysis of the key trends in each segment of the market, along with forecasts at the country and regional levels for 2026-2034. Our report has categorized the market based on product, route of administration, application, and end user.

Product Insights:

• Infant Nutrition
• Parental Nutrition
• Enteral Nutrition

The report has provided a detailed breakup and analysis of the market based on product. This includes infant nutrition, parental nutrition, and enteral nutrition.

Route of Administration Insights:

• Oral
• Enteral
• Parenteral

A detailed breakup and analysis of the market based on the route of administration have also been provided in the report. This includes oral, enteral, and parenteral.

Application Insights:

• Cancer
• Malnutrition
• Metabolic Disorders
• Gastrointestinal Disorders
• Neurological Disorders
• Others

A detailed breakup and analysis of the market based on the application have also been provided in the report. This includes cancer, malnutrition, metabolic disorders, gastrointestinal disorders, neurological disorders, and others.

End User Insights:

• Pediatric
• Adults
• Geriatric

A detailed breakup and analysis of the market based on the end user have also been provided in the report. This includes pediatric, adults, and geriatric.

Regional Insights:

• Seoul Capital Area
• Yeongnam (Southeastern Region)
• Honam (Southwestern Region)
• Hoseo (Central Region)
• Others

The report has also provided a comprehensive analysis of all the major regional markets, which include Seoul Capital Area, Yeongnam (Southeastern Region), Honam (Southwestern Region), Hoseo (Central Region), and others.

COMPETITIVE LANDSCAPE:

The market research report has also provided a comprehensive analysis of the competitive landscape. Competitive analysis such as market structure, key player positioning, top winning strategies, competitive dashboard, and company evaluation quadrant has been covered in the report. Also, detailed profiles of all major companies have been provided.

KEY QUESTIONS ANSWERED IN THIS REPORT
How has the South Korea clinical nutrition market performed so far and how will it perform in the coming years?
What is the breakup of the South Korea clinical nutrition market on the basis of product?
What is the breakup of the South Korea clinical nutrition market on the basis of route of administration?
What is the breakup of the South Korea clinical nutrition market on the basis of application?
What is the breakup of the South Korea clinical nutrition market on the basis of end user?
What is the breakup of the South Korea clinical nutrition market on the basis of region?
What are the various stages in the value chain of the South Korea clinical nutrition market?
What are the key driving factors and challenges in the South Korea clinical nutrition market?
What is the structure of the South Korea clinical nutrition market and who are the key players?
What is the degree of competition in the South Korea clinical nutrition market?

Contents

1 PREFACE

2 SCOPE AND METHODOLOGY

2.1 Objectives of the Study
2.2 Stakeholders
2.3 Data Sources
  2.3.1 Primary Sources
  2.3.2 Secondary Sources
2.4 Market Estimation
  2.4.1 Bottom-Up Approach
  2.4.2 Top-Down Approach
2.5 Forecasting Methodology

3 EXECUTIVE SUMMARY

4 SOUTH KOREA CLINICAL NUTRITION MARKET - INTRODUCTION

4.1 Overview
4.2 Market Dynamics
4.3 Industry Trends
4.4 Competitive Intelligence

5 SOUTH KOREA CLINICAL NUTRITION MARKET LANDSCAPE

5.1 Historical and Current Market Trends (2020-2025)
5.2 Market Forecast (2026-2034)

6 SOUTH KOREA CLINICAL NUTRITION MARKET - BREAKUP BY PRODUCT

6.1 Infant Nutrition
  6.1.1 Overview
  6.1.2 Historical and Current Market Trends (2020-2025)
  6.1.3 Market Forecast (2026-2034)
6.2 Parental Nutrition
  6.2.1 Overview
  6.2.2 Historical and Current Market Trends (2020-2025)
  6.2.3 Market Forecast (2026-2034)
6.3 Enteral Nutrition
  6.3.1 Overview
  6.3.2 Historical and Current Market Trends (2020-2025)
  6.3.3 Market Forecast (2026-2034)

7 SOUTH KOREA CLINICAL NUTRITION MARKET - BREAKUP BY ROUTE OF ADMINISTRATION

7.1 Oral
  7.1.1 Overview
  7.1.2 Historical and Current Market Trends (2020-2025)
  7.1.3 Market Forecast (2026-2034)
7.2 Enteral
  7.2.1 Overview
  7.2.2 Historical and Current Market Trends (2020-2025)
  7.2.3 Market Forecast (2026-2034)
7.3 Parenteral
  7.3.1 Overview
  7.3.2 Historical and Current Market Trends (2020-2025)
  7.3.3 Market Forecast (2026-2034)

8 SOUTH KOREA CLINICAL NUTRITION MARKET - BREAKUP BY APPLICATION

8.1 Cancer
  8.1.1 Overview
  8.1.2 Historical and Current Market Trends (2020-2025)
  8.1.3 Market Forecast (2026-2034)
8.2 Malnutrition
  8.2.1 Overview
  8.2.2 Historical and Current Market Trends (2020-2025)
  8.2.3 Market Forecast (2026-2034)
8.3 Metabolic Disorders
  8.3.1 Overview
  8.3.2 Historical and Current Market Trends (2020-2025)
  8.3.3 Market Forecast (2026-2034)
8.4 Gastrointestinal Disorders
  8.4.1 Overview
  8.4.2 Historical and Current Market Trends (2020-2025)
  8.4.3 Market Forecast (2026-2034)
8.5 Neurological Disorders
  8.5.1 Overview
  8.5.2 Historical and Current Market Trends (2020-2025)
  8.5.3 Market Forecast (2026-2034)
8.6 Others
  8.6.1 Historical and Current Market Trends (2020-2025)
  8.6.2 Market Forecast (2026-2034)

9 SOUTH KOREA CLINICAL NUTRITION MARKET - BREAKUP BY END USER

9.1 Pediatric
  9.1.1 Overview
  9.1.2 Historical and Current Market Trends (2020-2025)
  9.1.3 Market Forecast (2026-2034)
9.2 Adults
  9.2.1 Overview
  9.2.2 Historical and Current Market Trends (2020-2025)
  9.2.3 Market Forecast (2026-2034)
9.3 Geriatric
  9.3.1 Overview
  9.3.2 Historical and Current Market Trends (2020-2025)
  9.3.3 Market Forecast (2026-2034)

10 SOUTH KOREA CLINICAL NUTRITION MARKET – BREAKUP BY REGION

10.1 Seoul Capital Area
  10.1.1 Overview
  10.1.2 Historical and Current Market Trends (2020-2025)
  10.1.3 Market Breakup by Product
  10.1.4 Market Breakup by Route of Administration
  10.1.5 Market Breakup by Application
  10.1.6 Market Breakup by End User
  10.1.7 Key Players
  10.1.8 Market Forecast (2026-2034)
10.2 Yeongnam (Southeastern Region)
  10.2.1 Overview
  10.2.2 Historical and Current Market Trends (2020-2025)
  10.2.3 Market Breakup by Product
  10.2.4 Market Breakup by Route of Administration
  10.2.5 Market Breakup by Application
  10.2.6 Market Breakup by End User
  10.2.7 Key Players
  10.2.8 Market Forecast (2026-2034)
10.3 Honam (Southwestern Region)
  10.3.1 Overview
  10.3.2 Historical and Current Market Trends (2020-2025)
  10.3.3 Market Breakup by Product
  10.3.4 Market Breakup by Route of Administration
  10.3.5 Market Breakup by Application
  10.3.6 Market Breakup by End User
  10.3.7 Key Players
  10.3.8 Market Forecast (2026-2034)
10.4 Hoseo (Central Region)
  10.4.1 Overview
  10.4.2 Historical and Current Market Trends (2020-2025)
  10.4.3 Market Breakup by Product
  10.4.4 Market Breakup by Route of Administration
  10.4.5 Market Breakup by Application
  10.4.6 Market Breakup by End User
  10.4.7 Key Players
  10.4.8 Market Forecast (2026-2034)
10.5 Others
  10.5.1 Historical and Current Market Trends (2020-2025)
  10.5.2 Market Forecast (2026-2034)

11 SOUTH KOREA CLINICAL NUTRITION MARKET – COMPETITIVE LANDSCAPE

11.1 Overview
11.2 Market Structure
11.3 Market Player Positioning
11.4 Top Winning Strategies
11.5 Competitive Dashboard
11.6 Company Evaluation Quadrant

12 PROFILES OF KEY PLAYERS

12.1 Company A
  12.1.1 Business Overview
  12.1.2 Products Offered
  12.1.3 Business Strategies
  12.1.4 SWOT Analysis
  12.1.5 Major News and Events
12.2 Company B
  12.2.1 Business Overview
  12.2.2 Products Offered
  12.2.3 Business Strategies
  12.2.4 SWOT Analysis
  12.2.5 Major News and Events
12.3 Company C
  12.3.1 Business Overview
  12.3.2 Products Offered
  12.3.3 Business Strategies
  12.3.4 SWOT Analysis
  12.3.5 Major News and Events
12.4 Company D
  12.4.1 Business Overview
  12.4.2 Products Offered
  12.4.3 Business Strategies
  12.4.4 SWOT Analysis
  12.4.5 Major News and Events
12.5 Company E
  12.5.1 Business Overview
  12.5.2 Products Offered
  12.5.3 Business Strategies
  12.5.4 SWOT Analysis
  12.5.5 Major News and Events

13 SOUTH KOREA CLINICAL NUTRITION MARKET - INDUSTRY ANALYSIS

13.1 Drivers, Restraints, and Opportunities
  13.1.1 Overview
  13.1.2 Drivers
  13.1.3 Restraints
  13.1.4 Opportunities
13.2 Porters Five Forces Analysis
  13.2.1 Overview
  13.2.2 Bargaining Power of Buyers
  13.2.3 Bargaining Power of Suppliers
  13.2.4 Degree of Competition
  13.2.5 Threat of New Entrants
  13.2.6 Threat of Substitutes
13.3 Value Chain Analysis

14 APPENDIX